ABproBio Reduces Convertible Bond Issuance to KRW 2 Billion and Corrects Issuer Name
- Reduced convertible bond issuance amount from KRW 3 billion to KRW 2 billion (for operating funds)
- Shares upon conversion decreased to 1,510,574 shares (from 2,265,861), representing 4.64% of total shares (from 7.95%), reducing dilution
- Corrected issuer name from 'Baek Je-woo' to 'Baek Jae-uk' (typo correction)
- Put option granted: early redemption starting 1 year after issuance, every 3 months, initial redemption rate 103%
- Conversion price KRW 1,324 per share, maturity 2029-03-30
- Total issued shares increased to 32,757,748 (from 28,468,972)
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: [Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)
- Company: Abpro Bio (195990)
- Submission: Abpro Bio Co., Ltd.
- Receipt: 04-30-2026